| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 05/06/2004 | EP1416046A1 Use of histamine receptor h3 gene in controlling body weight or food intake |
| 05/06/2004 | EP1415997A1 Polypeptides relating to signal transfer of advanced glycation end product receptor |
| 05/06/2004 | EP1415994A1 Retinal pigmented epithelium derived neurotrophic factor |
| 05/06/2004 | EP1415665A2 BHV5 mutants |
| 05/06/2004 | EP1415659A1 BAFF, inhibitors thereof and their use in the modulation of the B-cell response |
| 05/06/2004 | EP1415163A2 Assay ofisomerised and/or optically inverted proteins and protein fragments |
| 05/06/2004 | EP1415162A2 Novel peptides for the diagnosis of schizophrenia |
| 05/06/2004 | EP1415155A2 Isolated human secreted proteins, nucleic acid molecules encoding human secreted proteins, and uses thereof |
| 05/06/2004 | EP1415154A2 Control of growth and repair of gastro-intestinal tissues by gastrokines and inhibitors |
| 05/06/2004 | EP1415006A2 Assay for identifying inhibitors of hiv rt dimerization |
| 05/06/2004 | EP1415005A2 Endogenous retroviruses up-regulated in prostate cancer |
| 05/06/2004 | EP1414984A2 Nucleic acid encoding polypeptide involved in cellular entrance of the prrs virus |
| 05/06/2004 | EP1414983A1 Isolated human secreted proteins, nucleic acid molecules encoding human secreted proteins, and uses thereof |
| 05/06/2004 | EP1414981A2 Fusion proteins for insect control |
| 05/06/2004 | EP1414980A2 Plant transcriptional repressor, proteic nuclear factors binding thereto, and uses thereof |
| 05/06/2004 | EP1414968A2 Nucleic acids for aminocoumarin biosynthesis |
| 05/06/2004 | EP1414966A2 Regulating nucleic acid for expressing a polynucleotide of interest specifically in the endothelium of a plant seed and uses thereof |
| 05/06/2004 | EP1414964A2 Vegf isoform |
| 05/06/2004 | EP1414963A2 Lipid-associated molecules |
| 05/06/2004 | EP1414962A1 Novel genetic products of ashbya gossypii, associated with the mechanisms of signal transduction and especially with the improvement of vitamin b2 production |
| 05/06/2004 | EP1414954A2 Epsti1, a gene induced by epithelial-stromal interaction in human breast cancer |
| 05/06/2004 | EP1414953A2 Identification and cloning of the receptor gene for symbiotic nitrogen fixation |
| 05/06/2004 | EP1414949A1 Cell and transgenic animal modelling human antigenic presentation and their uses |
| 05/06/2004 | EP1414948A2 Inhibition of apoptosis process and improvement of cell performance |
| 05/06/2004 | EP1414940A2 Expression of functional human olfactory cyclic nucleotide gated (cng) channel in recombinant host cells and use thereof in cell based assays to identify smell modulators |
| 05/06/2004 | EP1414939A2 Seed-preferred regulatory elements and uses thereof |
| 05/06/2004 | EP1414866A2 Fgf-affinity chromatography |
| 05/06/2004 | EP1414864A2 Isolated human secreted proteins, nucleic acid molecules encoding human secreted proteins, and uses thereof |
| 05/06/2004 | EP1414863A2 Isolated human secreted proteins, nucleic acid molecules encoding human secreted proteins, and uses thereof |
| 05/06/2004 | EP1414857A1 Factor viii separation |
| 05/06/2004 | EP1414856A2 Modified calcitonin |
| 05/06/2004 | EP1414855A2 Peptide inhibiting platelet derived growth factor (pdgf-bb) and fibroblast growth factor (bfgf) activity |
| 05/06/2004 | EP1414854A1 Method for inducing a conformational transition in proteins such as pathogenic/infectious proteins |
| 05/06/2004 | EP1414853A2 Method for studying the effects of commensal microflora on mammalian intestine and treatments of gastrointestinal-associated disease based thereon |
| 05/06/2004 | EP1414852A2 Human secreted proteins, their encoding pulynucleotides, and uses thereof |
| 05/06/2004 | EP1414851A2 Cellular virus receptors and methods of use. |
| 05/06/2004 | EP1414850A2 Genetically modified cyclic-nucleotide controlled ion channels and the use thereof |
| 05/06/2004 | EP1414848A2 Replikin peptides and uses thereof |
| 05/06/2004 | EP1414847A2 Isolated human secreted proteins, nucleic acid molecules encoding human secreted proteins, and uses thereof |
| 05/06/2004 | EP1414846A2 Molecule |
| 05/06/2004 | EP1414845A2 Human secreted proteins |
| 05/06/2004 | EP1414844A2 Isolated human secreted proteins, nucleic acid molecules encoding human secreted proteins, and uses thereof |
| 05/06/2004 | EP1414498A2 Stabilized formulations of interferons with sulfoalkyl ether cyclodextrins |
| 05/06/2004 | EP1414488A2 Mycobacterial vaccines |
| 05/06/2004 | EP1414483A1 Agonists and antagonists of moxifin for the treatment of metabolic disorders |
| 05/06/2004 | EP1414478A2 Inhibition of neurodegeneration |
| 05/06/2004 | EP1414477A2 Repeat sequences of the ca125 gene and their use for diagnostic and therapeutic interventions |
| 05/06/2004 | EP1414472A1 Method for preparing fetuin and polypeptide to induce apoptosis |
| 05/06/2004 | EP1414471A2 Therapeutic agents comprising pro-apoptotic proteins |
| 05/06/2004 | EP1414422A2 Isolated human secreted proteins, nucleic acid molecules encoding human secreted proteins, and uses thereof |
| 05/06/2004 | EP1414310A1 Method for the preparation of gliadin-and glutenin-rich fractions out of gluten in an aqueous medium and in the presence of an acid |
| 05/06/2004 | EP1414307A1 Method of enhancing the extraction of proteinase inhibitors |
| 05/06/2004 | EP1414299A2 Substantially homogeneous bio-affecting material having a pre-determined ratio of bioaffecting component to cell targeting component, the method for making such a material and the method of its use |
| 05/06/2004 | EP1414297A2 Sodium dodecyl sulfate compositions for inactivating prions |
| 05/06/2004 | EP1414288A2 Sugar and lipid metabolism regulators in plants iii |
| 05/06/2004 | EP1206489B1 Orally active peptides that prevent cell damage and death |
| 05/06/2004 | EP1007647B1 High level of expression of ingap |
| 05/06/2004 | EP0949335B1 Process for preparing purified dimer of bone-derived factor |
| 05/06/2004 | EP0889955B1 Recombinant phages |
| 05/06/2004 | EP0871466B1 Linear and cyclic peptides for the treatment or prevention of eczema/dermatitis |
| 05/06/2004 | EP0821696B1 Peptide antagonists of cellular mitogenesis and motogenesis and their therapeutic use |
| 05/06/2004 | EP0819173B1 Mutant of the erythrina caffra type inhibitor and the use of the said mutant for purifying serin proteases |
| 05/06/2004 | EP0792287B1 Peptide analogs of human myelin basic protein |
| 05/06/2004 | EP0729509B1 Vaccine against mumps containing a jeryl-lynn virus strain |
| 05/06/2004 | EP0589004B2 Process for the determination of peptides corresponding to immunologically important epitopes of hcv |
| 05/06/2004 | DE10305082A1 MIA-2 Protein MIA-2 protein |
| 05/06/2004 | DE10248751A1 Dyslokalisationsmoleküle und deren Verwendung Dyslokalisationsmoleküle and their use |
| 05/06/2004 | DE10054639B4 Verwendung von RanBPM als Co-Modulator von Steroidhormonrezeptoren Use of RanBPM as co-modulator of steroid hormone receptors |
| 05/06/2004 | CA2503442A1 Methods of diagnosing ischemia using eif-5a |
| 05/06/2004 | CA2503305A1 Methods for treating viral infection using il-28 and il-29 |
| 05/06/2004 | CA2503164A1 Gpr54 knock-out mammals and screening methods using them |
| 05/06/2004 | CA2502696A1 Compositions and methods for treating human papillomavirus-mediated disease |
| 05/06/2004 | CA2502685A1 Cdkl1 as modifier of branching morphogenesis and methods of use |
| 05/06/2004 | CA2502684A1 Mapk7 as modifier of branching morphogenesis and methods of use |
| 05/06/2004 | CA2502677A1 Map2k6 as modifier of branching morphogenensis and methods of use |
| 05/06/2004 | CA2502268A1 Methods for vaccinating against malaria |
| 05/06/2004 | CA2502118A1 Glp-1 derivatives and transmicosal absorption preparations thereof |
| 05/06/2004 | CA2501684A1 Conjugates of tc complexes and targeting moieties and their use in mri diagnostic |
| 05/06/2004 | CA2501677A1 Treatment of diabetes |
| 05/06/2004 | CA2501606A1 Method for diagnosing renal diseases or predispositions |
| 05/06/2004 | CA2501393A1 Genes and proteins for the biosynthesis of the glycopeptide antibiotic a40926 |
| 05/06/2004 | CA2501231A1 2-alkyl-(2-amino-3-aryl-propionyl)-piperazine derivatives and related compounds as melanocortin receptor ligands for the treatment of obesity |
| 05/06/2004 | CA2497909A1 Low dose methods for treating disorders in which tnf.alpha. activity is detrimental |
| 05/06/2004 | CA2482744A1 Hiv envelope-cd4 complexes and hybrids |
| 05/06/2004 | CA2468903A1 Endogenous retrovirus up-regulated in prostate cancer |
| 05/05/2004 | CN1494595A Rice-origin high expression polypeptide chain elongation factor promoter and method of using the same |
| 05/05/2004 | CN1494593A Modified ciliary neurotrophic factor (CNTF) with reduced immunogenicity |
| 05/05/2004 | CN1494592A Nucleic acid expressed in hypothalamus or muscle tissue in obese animals |
| 05/05/2004 | CN1494591A Polynucleotide useful for modulating cancer cell proliferation |
| 05/05/2004 | CN1494590A Modified thrombopoietin with reduced immunogenicity |
| 05/05/2004 | CN1494589A 方法 Method |
| 05/05/2004 | CN1494552A Flt 4 (VEGFR-3) as target for tumor imaging and anti-tumor therapy |
| 05/05/2004 | CN1494551A Modified granulocyte macrophage colony stimulating factor (GM-CSF) with reduced immunogenicity |
| 05/05/2004 | CN1494432A Noval vaccine for mulation consisting of DNA vaccine inactivated virus |
| 05/05/2004 | CN1494430A Modified protamine with reduced immunogenicity |
| 05/05/2004 | CN1493597A Separation dendron shaped cell membrane protein gene |
| 05/05/2004 | CN1493596A Polypeptide-human programming cell death protein 22 and polynucleotide for coding said polypeptide |
| 05/05/2004 | CN1493595A Polypeptide-human tumour protein 20 and polynucleotide for coding said polypeptide |
| 05/05/2004 | CN1493594A Polypeptide-human signal peptide secretory protein I 10 and polynucleolide for coding said polypeptide |
| 05/05/2004 | CN1493593A Polypeptide-human transcription regulate and control protein 44 and polynucleotide for coding said polypeptide |